Stocks and Investing
Stocks and Investing
Mon, June 6, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sun, June 5, 2022
[ 12:00 AM ] - WOPRAI
Fri, June 3, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Justin Zelin Maintained (CASI) at Strong Buy with Increased Target to $21 on, Jun 3rd, 2022
Justin Zelin of BTIG, Maintained "CASI Pharmaceuticals, Inc." (CASI) at Strong Buy with Increased Target from $4 to $21 on, Jun 3rd, 2022.
Justin has made no other calls on CASI in the last 4 months.
There is 1 other peer that has a rating on CASI. Out of the 1 peers that are also analyzing CASI, 0 agree with Justin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Justin
- Sean Lee of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $30 on, Monday, May 16th, 2022
Contributing Sources